Holen Sie sich die Stockscreener-App
52.45
2.53%
-1.36
Handel nachbörslich:
52.45
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
8.23%
0.434
|
0.401 | 0.264 | 0.086 | - |
| Cost Of Revenue |
26.22%
0.273
|
0.37 | 0.26 | 0.279 | - |
Selling, General, and Administrative
|
28.31%
8.457
|
6.591 | - | - | - |
| Costs And Expenses |
31.48%
25.71
|
19.55 | 18.52 | 20.45 | 20.27 |
| Operating Income/Loss |
31.97%
-25.27
|
-19.15 | -18.25 | -20.37 | -20.27 |
| Nonoperating Income/Loss |
8.08%
0.615
|
0.569 | 0.82 | 0.982 | 1.107 |
| Net Income/Loss |
32.70%
-24.66
|
-18.58 | -17.43 | -19.39 | -19.17 |
| Basic Average Shares |
1.77%
69.20
|
67.99 | 0.1323 | 67.39 | 67.28 |
| Basic Earnings Per Share |
33.33%
-0.36
|
-0.27 | -0.26 | -0.29 | -0.28 |
1.22%
2.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):